Biocon Ltd signs an exclusive licensing and supply agreement for generic Ozempic commercialization in Brazil with Biomm ...
Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, has announced the signing of an exclusive licensing and supply agreement with Biomm S.A., a specialty pharmaceutical company in Brazil, for the …